Regenxbio Inc
Biotechnology
Healthcare
RGNX
51.43 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.05
52 week high
12.95
high
9.12
52 week low
0.00
previous Close
9.06
P/E ratio
market cap
415 M
div yield
0
net profit margin
0.00 %
-6.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top